Mirati Therapeutics Inc. (MRTX) has offered to sell 4.35 million shares of its common stock to the public at a price of $5.60 each. The gross proceeds from the offering are expected to be about $65.0 million, and is scheduled to close on or about January 11, 2017.
from RTT - Biotech http://ift.tt/2iU7sh5
via IFTTT
No comments:
Post a Comment